Carerx Corporation · TSX:CRRX
Carerx — Investor Presentation (August 2025)
16 slides from Carerx's investor presentation, August 2025
Slide 1: Investor Presentation August 2025
INVESTOR PRESENTATION August 2025 TSX: CRRX
Slide 2: Cautionary Statements
Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past pe
Slide 3: Canada's leading provider of specialty pharmacy services to seniors housing communities
Canada’s leading provider of specialty pharmacy services to seniors housing communities Enhancing the health of seniors with complex medication needs with high-touch, same-day delivery of specially packaged medications 3
Slide 4: Canadian Market
Canadian Market 1 in 5 Typical Seniors in Adults 65+ consume Canadians long-term care take ~40% are aged 4 to 12 of prescription drugs & medications daily ~25% 65 or older of OTC drugs Source: Statistics Canada An aging population is driving unprecedented demand for 4 medications and care services i
Slide 5: Operational and Financial Highlights
Operational and Financial Highlights ~90,000 ~1,480 Coast-to- Coast Average Beds Seniors housing Footprint Serviced communities served 25 5+ Fulfillment centres Year average contract term CareRx with our largest customers Tripled Average Beds Serviced since ~90,000 2020 $91.4M $8.0M 8.8% 2025 Q2 202
Slide 6: Comprehensive Services Offering
Comprehensive Services Offering Servicing Seniors Seniors Living Living Pharmacists Distribution Service Facilities Facilities Onsite geriatric-certified clinical A leading distributor of medical Automated dispensing pharmacists + pharmacist-led supplies and continence cabinets and medication medica
Slide 7: Investment Highlights
Investment Highlights 1 2 3 4 Differentiated Contracted Increasing Infrastructure & Strategy Recurring Revenue Demand Technology Largest pure-play 5+ year contract length Increasing seniors National platform with pharmacy focused on with largest customers population and best-in-class long-term care
Slide 8: Differentiated Strategy
Differentiated Strategy Retail Facility move-in consultation and specialized geriatric visits Deprescribing and routine medication reviews for safety & health ? 24/7 emergency medications and availability Free caregiver education and daily delivery ? Reduced errors with specialized packa
Slide 9: Contracted Recurring Revenue
Contracted Recurring Revenue • 5+ year contract length with largest customers funded by government payors • Capitated fee (fee/bed/month or fee-for-service) model for medications dispensed and clinical services • Payments billed directly to government and insurance • Non-covered medications paid for
Slide 10: Increasing Demand
Increasing Demand Currently CareRx 1,025,000 >500,000 90,000 beds congregate care beds in Canada1 18% Canada’s over 65 population is projected to grow by 2.7 million Current market has The Ontario government has over the next 5 years ~500,000 beds1 pledged to build 58,000 new or upgraded Spending on
Slide 11: Infrastructure & Technology
Infrastructure & Technology Key Technologies Supported by LTC Pharmacies PacMed BD Rowa Dose • Unit dose “pouch” packaged medications (PacMed and BD Rowa Dose) • eMAR software • Automated dispensing cabinets (ADCs) • Digital prescribing technologies (CPOE) Technology • Medication incident management
Slide 12: Growth Strategy
Growth Strategy • Broadening scope of products and services (e.g. Revicare, BOOMR., etc.) Organic Bed Wins • Leverage scale & capabilities to provide superior pharmacy services offering • Increased focus on expansion to other congregate care settings • LTC occupancy increasing post-Covid Existing Pa
Slide 13: Financial Performance
Financial Performance Revenue Adj. EBITDA1 Operating Cash Flow $38.0 $381.7 $32.3 $370.7 $366.7 $30.3 $28.7 $27.4 $262.6 $22.9 $22.3 $7.3 FY '21 FY '22 FY '23 FY '24 FY '21 FY '22 FY '23 FY '24 FY '21 FY '22 FY '23 FY '24 Note: All figures in millions. 1. Adjusted EBITDA is a non-IFRS financial meas
Slide 14: Experienced Leadership Team
Experienced Leadership Team Puneet Khanna Alpinder Grewal President & Chief Executive Officer Chief Operating Officer Former Chief Commercial Officer, COO and SVP, Corporate Joined CareRx in 2014 and has held various roles with Development of CareRx; former CEO of MED e-care Healthcare increasing re
Slide 15: Capitalization
Capitalization Ownership At June 30, 2025 Common Stock Ownership Shares Outstanding 63.1M Share Price1 C$2.83 Yorkville Asset Management 16,301,305 25.8% Market Cap C$178.5M Directors & Officers 6,811,737 10.8% Cash $8.7M Polar Asset Management 10,095,107 16.0% Debt $43.5M Other 29,854,806 47.3% Ter
Slide 16: os
os